Rigel Pharmaceuticals
RIGL
#6997
Rank
$0.68 B
Marketcap
$36.81
Share price
-3.28%
Change (1 day)
68.01%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): $0.12 Billion USD

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are $0.29 Billion USD. In 2025 the company made an earning of $0.12 Billion USD, an increase over its 2024 earnings that were of $26.28 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.12 B-0.21%
2025 $0.12 B391.35%
2024 $26.28 M-244.27%
2023 -$18.22 Million-66.79%
2022 -$54.87 Million340.73%
2021 -$12.45 Million-56.15%
2020 -$28.4 Million-57.34%
2019 -$66.56 Million-7.66%
2018 -$72.08 Million-9.47%
2017 -$79.62 Million24.46%
2016 -$63.98 Million23.63%
2015 -$51.75 Million-43.29%
2014 -$91.25 Million2.5%
2013 -$89.03 Million
2010 $37.85 M-133.97%
2009 -$0.12 Billion-18.49%
2008 -$0.14 Billion71.91%
2007 -$79.53 Million84.74%
2006 -$43.05 Million-10.17%
2005 -$47.93 Million-15.73%
2004 -$56.87 Million39.29%
2003 -$40.83 Million10.3%
2002 -$37.02 Million48.3%
2001 -$24.97 Million-2.13%
2000 -$25.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
$9.08 B 6,951.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$14.66 B 11,278.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-$0.12 Billion-185.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-$0.14 Billion-201.34%๐Ÿ‡บ๐Ÿ‡ธ USA